EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impairment of Group I Metabotropic Glutamate Receptors in the Dorsal Striatum of the R451C ‐Neuroligin 3 Mouse Model of Autism Spectrum Disorder

Maria Meringolo, Martina Montanari, Simona D'Antoni, Giuseppina Martella, Ilham El Atiallah, Giulia Ponterio, Annalisa Tassone, Ingrid Reverte, Daniele Caprioli, Georgios Strimpakos, Luisa Pieroni, Maria Vincenza Catania und 1 weitere

Journal of Neurochemistry · 2025

DOI: 10.1111/jnc.70253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von Maria Meringolo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Receptors, Metabotropic Glutamate, Corpus Striatum, Nerve Tissue Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Autism Research Institute, European Union - Next Generation EU Mission 4 Comp 2.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human genetics indicates enrichment of synaptic pathway‐related mutations in Autism Spectrum Disorder (ASD). Accordingly, several preclinical studies have reported synaptic alterations in different brain areas of relevant ASD mouse models. In particular, we previously showed that corticostriatal long‐term synaptic depression is impaired in the dorsal striatum of mice carrying the ASD‐associated R451C mutation in the neuroligin3 (NL3) gene, coding for the postsynaptic protein neuroligin 3. Here, we used behavioral, proteomic, biochemical, and electrophysiological approaches to explore the dorsal striatum‐dependent functions in the R451C‐NL3 knock‐in mouse model of ASD. A detailed behavioral analysis confirmed striatum‐dependent alterations in these mice. We further explored the synaptic function in the dorsal striatum, revealing modifications of the glutamatergic postsynaptic density protein composition and the impairment of different forms of corticostriatal long‐term synaptic plasticity involving the activation of group I metabotropic glutamate receptors, namely activity‐dependent depression and potentiation, and pharmacological 3,5‐DHPG‐induced synaptic depression. Notably, activation of group I metabotropic glutamate receptors was not able to potentiate NMDA receptor‐mediated currents despite unaltered kinetics of the ionotropic receptors. Protein expression levels of type 5 metabotropic glutamate receptors were reduced at striatal synapses. Overall, our findings point to a significant impairment of metabotropic glutamate receptor type 5 signaling in NL3 knock‐in mice, affecting the dorsal striatum circuitry, which is implicated in autism‐related behaviors. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderReceptors, Metabotropic GlutamateCorpus StriatumNerve Tissue ProteinsMembrane ProteinsCell Adhesion Molecules, NeuronalAnimalsMiceDisease Models, AnimalMaleMice, Inbred C57BLGene Knock-In TechniquesMice, TransgenicNeuronal Plasticity

Stichwörter der Autor:innen

behaviorcorticostriatal synapseselectrophysiologyglutamate metabotropic receptorslong‐term synaptic plasticity

Substanzen

Receptors, Metabotropic Glutamateneuroligin 3Nerve Tissue ProteinsMembrane ProteinsCell Adhesion Molecules, Neuronal

Autor:innen und Institutionen

  • Laboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy.
  • Saint Camillus International University of Health and Medical Sciences, Rome, Italy.
  • Institute for Biomedical Research and Innovation, National Research Council, Catania, Italy.
  • Department of Physiology and Pharmacology, Sapienza University, and Laboratory of Behavioral Neuropharmacology, IRCCS Fondazione Santa Lucia, Rome, Italy.
  • Institute of Biochemistry and Cell Biology, National Research Council, Monterotondo, Italy.
  • Proteomics and Metabolomics Unit, IRCCS Fondazione Santa Lucia, Rome, Italy.

ORCID-Profile: Paola Bonsi

Förderung

  • Autism Research Institute
  • European Union - Next Generation EU Mission 4 Comp 2

Zitieren

APA

Meringolo, M., Montanari, M., D'Antoni, S., Martella, G., El Atiallah, I., Ponterio, G., Tassone, A., Reverte, I., Caprioli, D., Strimpakos, G., Pieroni, L., Catania, M. V., & Bonsi, P. (2025). Impairment of Group I Metabotropic Glutamate Receptors in the Dorsal Striatum of the R451C ‐Neuroligin 3 Mouse Model of Autism Spectrum Disorder. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70253

Vancouver

Meringolo M, Montanari M, D'Antoni S, Martella G, El Atiallah I, Ponterio G, et al. Impairment of Group I Metabotropic Glutamate Receptors in the Dorsal Striatum of the R451C ‐Neuroligin 3 Mouse Model of Autism Spectrum Disorder. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70253

BibTeX
@article{Meringolo2025,
  author = {Meringolo, Maria and Montanari, Martina and D'Antoni, Simona and Martella, Giuseppina and El Atiallah, Ilham and Ponterio, Giulia and Tassone, Annalisa and Reverte, Ingrid and Caprioli, Daniele and Strimpakos, Georgios and Pieroni, Luisa and Catania, Maria Vincenza and Bonsi, Paola},
  title = {Impairment of Group I Metabotropic Glutamate Receptors in the Dorsal Striatum of the R451C ‐Neuroligin 3 Mouse Model of Autism Spectrum Disorder},
  journal = {Journal of Neurochemistry},
  year = {2025},
  doi = {10.1111/jnc.70253}
}
Kostenlos starten →